Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
United States Gasoline Fund Lp
UGA
US Stock MarketDetailed Quotes
Cullinan Therapeutics (CGEM)
- 13.880
- -0.180-1.28%
Trading Mar 26 12:24 ET
840.10MMarket Cap-4.13P/E (TTM)
14.290High13.810Low244.31KVolume13.880Open14.060Prev Close3.42MTurnover0.57%Turnover RatioLossP/E (Static)60.53MShares16.74052wk High2.06P/B599.73MFloat Cap5.68052wk Low--Dividend TTM43.21MShs Float59.850Historical High--Div Yield TTM3.41%Range %5.680Historical Low14.009Avg Price1Lot Size
Cullinan Therapeutics (CGEM) Key Financial Indicators
CGEM Earnings per Share (EPS)
According to the latest financial report of Cullinan Therapeutics, the latest earnings per share (TTM) for the company is -0.77. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
CGEM Free Cash Flow (FCF)
Interested in knowing about Cullinan Therapeutics's free cash flow? The latest report shows it as -38.12M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
CGEM Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Cullinan Therapeutics shows that the company's current ratio is 10.25, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
CGEM Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Cullinan Therapeutics, the quick ratio is 10.01, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
CGEM Return on Equity (ROE)
Want to learn more about the financial health of Cullinan Therapeutics? The latest ROE figure is -11.79%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
CGEM Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Cullinan Therapeutics, the total asset return on investment (ROA) is -10.88%.
Currency: USD
Quarterly
Loading...
CGEM Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Cullinan Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
CGEM Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Cullinan Therapeutics, the net profit margin is 7.49%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Recently, the prospect of a ceasefire negotiation between the US and Iran has been dominating market sentiment. Previously, news that the US
富哥搞钱
Feb 28 17:22
Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.